---
title: "Aura Biosciences holders approve raising authorized shares to 500,000,000"
url: "https://aibio.space/news/aura-biosciences-holders-approve-raising-authorized-shares-500-000-000/"
publisher: "aibio.space (Biotech Investor Relations News)"
date: "2026-08-05"
section: "Listings"
tickers: "NASDAQ:AURA"
source: "https://www.sec.gov/Archives/edgar/data/1501796/000119312526335157/aura-20260805.htm"
summary: "Authorized common shares rise from 150,000,000. The August 5, 2026 special meeting also approved an amendment to the 2021 Stock Option and Incentive Plan."
---

By the aibio.space news desk.

Sources

- [Aura Biosciences, Inc. 8-K (2026-08-05)](https://www.sec.gov/Archives/edgar/data/1501796/000119312526335157/aura-20260805.htm)

[AURA](https://aibio.space/companies/aura-biosciences/)

2026-08-05

# Aura Biosciences holders approve raising authorized shares to 500,000,000

Tickers [AURA](https://aibio.space/companies/aura-biosciences/)

Authorized common shares rise from 150,000,000. The August 5, 2026 special meeting also approved an amendment to the 2021 Stock Option and Incentive Plan.

## Key facts

- **Company**: Aura Biosciences, Inc. (NASDAQ: AURA)

- **News type**: Listings

- **Primary source**: [Aura Biosciences, Inc. 8-K (2026-08-05)](https://www.sec.gov/Archives/edgar/data/1501796/000119312526335157/aura-20260805.htm)

*A columned courthouse. Photo: Carol M Highsmith, CC0, via rawpixel. The picture shows the field, not the companies named.*

Aura Biosciences, Inc. (Nasdaq: [AURA](https://aibio.space/companies/aura-biosciences/)) held a Special Meeting of Stockholders on August 5, 2026. Stockholders approved an amendment to the company's Tenth Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 150,000,000 to 500,000,000.

The proposal passed with 62,993,701 votes for, 26,496,186 against and 839 abstentions. There were no broker non-votes.

Stockholders also approved Amendment No. 1 to the 2021 Stock Option and Incentive Plan. That vote was 46,369,676 for, 27,372,773 against, 819 abstentions and 15,747,458 broker non-votes.

As of June 12, 2026, the record date, 103,436,416 shares of common stock were outstanding and entitled to vote. A total of 89,490,726 shares were represented in person or by proxy, which made a quorum.

The company filed its Definitive Proxy Statement on Schedule 14A on June 29, 2026. No other matters were submitted to a vote.

[Report an error](https://aibio.space/reputation/#correction)

## Companies in this story

AURA

Aura Biosciences, Inc.

NASDAQ · United States

Open the starter desk

## More in Listings

Listings

### [Propanc Biopharma faces Nasdaq delisting on bid price, plans to appeal](https://aibio.space/news/propanc-biopharma-faces-nasdaq-delisting-bid-price-plans-appeal/)

Oct 29, 2026

Listings

### [Reviva asks stockholders to approve reverse split of up to 1-for-100](https://aibio.space/news/reviva-asks-stockholders-approve-reverse-split-up-1-100/)

Oct 29, 2026

Listings

### [Nasdaq to delist Glucotrack shares after bid price exception ends](https://aibio.space/news/nasdaq-delist-glucotrack-shares-after-bid-price-exception-ends/)

Oct 28, 2026

---
Source page: https://aibio.space/news/aura-biosciences-holders-approve-raising-authorized-shares-500-000-000/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Aura Biosciences holders approve raising authorized shares to 500,000,000", 2026-08-05, https://aibio.space/news/aura-biosciences-holders-approve-raising-authorized-shares-500-000-000/